The liver sieve and atherosclerosis

被引:61
作者
Fraser, Robin [4 ]
Cogger, Victoria C. [1 ,2 ,3 ]
Dobbs, Bruce [4 ,5 ]
Jamieson, Hamish [6 ]
Warren, Alessandra [1 ,2 ,3 ]
Hilmer, Sarah N. [3 ,7 ]
Le Couteur, David G. [1 ,2 ,3 ]
机构
[1] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia
[2] Concord Hosp, ANZAC Med Res Inst, Sydney, NSW 2139, Australia
[3] Univ Sydney, Sydney, NSW 2006, Australia
[4] Univ Otago, Dept Pathol, Christchurch, New Zealand
[5] Canterbury Dist Hlth Board, Dept Surg & Gastroenterol, Christchurch, New Zealand
[6] Canterbury Dist Hlth Board, Dept Med, Christchurch, New Zealand
[7] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia
关键词
Ageing; atherosclerosis; chylomicron remnant; diabetes mellitus; fenestration; hyperlipidaemia; liver disease; liver sieve; liver sinusoidal endothelial cell; AGE-RELATED PSEUDOCAPILLARIZATION; HEPATIC SINUSOIDAL ENDOTHELIUM; OLD-AGE; PSEUDOMONAS-AERUGINOSA; RAT MODEL; LIPOPROTEIN METABOLISM; INDUCED DEFENESTRATION; FENESTRAL CONTRACTION; REMNANT LIPOPROTEINS; CELLS;
D O I
10.1097/PAT.0b013e328351bcc8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The 'liver sieve' is a term developed to describe the appearance and the role of fenestrations in the liver sinusoidal endothelial cell (LSEC). LSECs are gossamer-thin cells that line the hepatic sinusoid and they are perforated with pores called fenestrations clustered in sieve plates. There is growing evidence that fenestrations act like a permselective ultrafiltration system which is important for the hepatic uptake of many substrates, particularly chylomicron remnant lipoproteins. The liver sieve is a very efficient exchange system, however in conditions such as hepatic cirrhosis and fibrosis, diabetes mellitus and old age, there is defenestration of the liver sieve. Such defenestration has been shown to influence the hepatic uptake of various substrates including lipoproteins. In the future, pharmacological manipulation of the liver sieve may play a number of therapeutic roles including the management of dyslipidaemia; increasing the efficiency of liver-targeted gene therapy; and improving regeneration of old livers.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 111 条
[21]   Hyperlipidemia and surfactants: The liver sieve is a link [J].
Cogger, Victoria C. ;
Hilmer, Sarah N. ;
Sullivan, David ;
Muller, Michael ;
Fraser, Robin ;
Le Couteur, David G. .
ATHEROSCLEROSIS, 2006, 189 (02) :273-281
[22]   Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations [J].
Cogger, Victoria C. ;
McNerney, Gregory P. ;
Nyunt, Tun ;
DeLeve, Laurie D. ;
McCourt, Peter ;
Smedsrod, Bard ;
Le Couteur, David G. ;
Huser, Thomas R. .
JOURNAL OF STRUCTURAL BIOLOGY, 2010, 171 (03) :382-388
[23]   Hepatic microvasculature in liver injury [J].
DeLeve, Laurie D. .
SEMINARS IN LIVER DISEASE, 2007, 27 (04) :390-400
[24]   Characterization of a reproducible rat model of hepatic veno-occlusive disease [J].
DeLeve, LD ;
McCuskey, RS ;
Wang, XD ;
Hu, LP ;
McCuskey, MK ;
Epstein, RB ;
Kanel, GC .
HEPATOLOGY, 1999, 29 (06) :1779-1791
[25]   Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome [J].
DeLeve, LD ;
Ito, Y ;
Bethea, NW ;
McCuskey, MK ;
Wang, XD ;
McCuskey, RS .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (06) :G1045-G1052
[26]   Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease) [J].
DeLeve, LD ;
Shulman, HM ;
McDonald, GB .
SEMINARS IN LIVER DISEASE, 2002, 22 (01) :27-41
[27]  
DOBBS BR, 1994, LIVER, V14, P230
[28]   The vesiculo-vacuolar organelle (VVO): A new endothelial cell permeability organelle [J].
Dvorak, AM ;
Feng, D .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (04) :419-431
[29]   The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity [J].
Elvevold, Kjetil ;
Smedsrod, Bard ;
Martinez, Inigo .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (02) :G391-G400
[30]  
FAWCETT DW, 1955, JNCI-J NATL CANCER I, V15, P1475